'Immediately Practice-Changing' Trial in Small Cell Lung Cancer

(MedPage Today) — CHICAGO — The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment of small cell lung cancer (SCLC), a practice-changing phase III trial showed.
In patients whose…

Source link : https://www.medpagetoday.com/meetingcoverage/asco/115891

Author :

Publish date : 2025-06-03 21:16:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

‘Immediately Practice-Changing’ Trial in Small Cell Lung Cancer

Infant RSV shot may be more effective than vaccines during pregnancy

Myeloma Trial Results Spark Talk of ‘Potential Cure’

Related Posts

Some Hormone Therapies Linked to Young-Onset Breast Cancer

A crucial methane-tracking satellite has died in orbit

ACIP Members Show Inexperience, Lack of Understanding at First Meeting, Experts Say

Senate Passes Trump’s Tax Bill With $1 Trillion in Health Cuts

HHS Confirms Contracts With Springer Nature Have Been Terminated

DREAMM-20 Hints at a More Tolerable Path for BCMA-Targeted Therapy in Myeloma

Some Hormone Therapies Linked to Young-Onset Breast Cancer

A crucial methane-tracking satellite has died in orbit

ACIP Members Show Inexperience, Lack of Understanding at First Meeting, Experts Say

Senate Passes Trump’s Tax Bill With $1 Trillion in Health Cuts

HHS Confirms Contracts With Springer Nature Have Been Terminated

DREAMM-20 Hints at a More Tolerable Path for BCMA-Targeted Therapy in Myeloma

Sleep and Alzheimer’s; NIH Cuts to Brain Research; Novel CTE Report

Physical Activity and Rehabilitation in Duchenne Muscular Dystrophy

Categories

Archives